Lennham Pharmaceuticals
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
53 Main St Ste 206, Concord, Massachuset...Phone Number
(617) 388-7171Website
www.lennham.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Lennham Pharmaceuticals
Lennham Pharmaceuticals focuses on enhancing the metabolic and pharmacological profiles of drugs through deuterium chemistry. The company is comprised of industry experts who leverage this underutilized technology to develop products with superior properties and strong patent protection. Their approach includes identifying chemical compounds for modification, generating experimental data to assess the impact of deuterium chemistry, and advancing products with high clinical success potential. Their intended clients are likely pharmaceutical companies and researchers seeking innovative drug solutions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lennham Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Lennham Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Lennham Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Lennham Pharmaceuticals has new funding data
Check out if Lennham Pharmaceuticals is spiking on competitors!
Lennham Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Lennham Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Lennham Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Lennham Pharmaceuticals
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Lennham Pharmaceuticals
Compare insights from companies similar to Lennham Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Lennham Pharmaceuticals
$5.5M
1-10
Private
-
2019
N/A
Company Profile Activity
Activity Insights
Lennham Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Lennham Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Lennham Pharmaceuticals.
Lennham Pharmaceuticals Tech Stack
A closer look at the technologies used by Lennham Pharmaceuticals
Lennham Pharmaceuticals News & Media
Lennham Pharmaceuticals Announces Issuance of U.S. Patent Covering Methods of Administering Psilocybin and Psilocin
CONCORD, Mass.--(BUSINESS WIRE)--Lennham’s discoveries are likely to cover information in the label of any future psilocybin- or psilocin-based product or related compounds.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Lennham Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Lennham Pharmaceuticals focuses on enhancing the metabolic and pharmacological profiles of drugs through deuterium chemistry. The company is comprised of industry experts who leverage this underutilized technology to develop products with superior properties and strong patent protection. Their approach includes identifying chemical compounds for mo... Read More
